Event category: Concurrent Session
Events
September 05, 2025
02:45 PM (EDT)
- 03:30 PM (EDT)
Regulatory Science in a Changing Landscape for Device Trials
Regulatory Science in a Changing Landscape for Device Trials
This session will highlight the challenges, current best practices, and how innovation will impact regulatory science, with a focus on first-in-human device trials. The session will highlight shared and unique challenges in different regions of the world, including Asia, Europe, and North America. Attendees will be armed with a better understanding of the key barriers and facilitators for successful first-in-human trials.
12:30 PM (EDT)
- 01:15 PM (EDT)
Imaging 2.0: Multi-Modal Insights for Complex EP Cases
Imaging 2.0: Multi-Modal Insights for Complex EP Cases
Jeffrey Winterfield
Innovations in imaging—ranging from real-time 3D/4D echo, advanced CT mapping to cardiac MRI—are reshaping electrophysiology. This session explores how novel visualization tools and AI-powered image processing can guide complex procedures while improving patient safety and outcomes.
September 06, 2025
10:45 AM (EDT)
- 11:30 AM (EDT)
AI and Machine Learning in Electrophysiology: From Research to Implementation
AI and Machine Learning in Electrophysiology: From Research to Implementation
James O'Hara | Janet K. Han | Lisa Roelle | Heather Ross | Lauren Rousseau
We will discuss key issues surrounding interoperability and integration, exploring innovative solutions for seamless data flow across multiple monitoring systems. Additionally, we will evaluate the role of AI to support clinical decision-making, enhancing both patient outcomes and operational efficiency. Join us to explore the future of remote monitoring and data management, and how innovations in this field are shaping the future of healthcare
September 05, 2025
04:45 PM (EDT)
- 05:30 PM (EDT)
Innovative Educational Strategies for Patients and Professionals
Innovative Educational Strategies for Patients and Professionals
Jill Schaeffer | Jamie Harris | Jeroen Hendriks | Samuel F. Sears | Julie Shea | Mellanie True Hills
This session will explore cutting-edge approaches to patient education, focusing on the integration of digital tools and interactive platforms. Participants will gain insights into the latest best practices for educating patients and healthcare professionals, enhancing engagement, understanding, and overall patient outcomes.
03:45 PM (EDT)
- 04:30 PM (EDT)
AI for the Failing Heart: From Early Detection to Remote Monitoring and Predictive Analytics
AI for the Failing Heart: From Early Detection to Remote Monitoring and Predictive Analytics
Marat Fudim
As healthcare shifts toward proactive interventions, AI holds the promise of detecting heart failure before overt symptoms appear. In this session, experts will discuss how machine learning and big-data analytics can arm clinicians with real-time insights to intervene at the earliest sign of HF decompensation. Attendees will gain an understanding of predictive models, novel monitoring tools, and the challenges involved in implementing such technologies on a broad scale.
09:45 AM (EDT)
- 10:30 AM (EDT)
Are Digital Innovations Accelerating Advances in Gene Therapy?
Are Digital Innovations Accelerating Advances in Gene Therapy?
With gene therapy advancing rapidly, how do digital innovations accelerate its impact on cardiovascular disease? This session explores the evolution of gene therapy trials, cutting-edge breakthroughs, and the role of AI, big data, and digital platforms in research, patient monitoring, and treatment optimization. Hear from experts and patient advocates as we examine whether technology is the key to making gene therapy more accessible, efficient, and transformative. Are we on the verge of a revolution, or just scratching the surface?
September 04, 2025
04:30 PM (EDT)
- 05:15 PM (EDT)
Clinical Workflow: Interoperability, Decision-Making, and Solutions – What’s the Missing Link?
Clinical Workflow: Interoperability, Decision-Making, and Solutions – What’s the Missing Link?
David Slotwiner
This session explores how AI integration, EMR advancements, and remote monitoring can enhance physician decision-making, streamline workflows, and improve patient care. Panelists will discuss the impact of AI on billing and physician hours, the role of device-driven insights in heart failure management, and how RNs and APPs contribute to effective communication and data management. Join us for an insightful discussion on leveraging technology to optimize clinical efficiency and patient outcomes.
04:30 PM (EDT)
- 05:15 PM (EDT)
AI at the Point of Care: Redesigning Documentation for Clinicians
AI at the Point of Care: Redesigning Documentation for Clinicians
Dhanunjaya R. Lakkireddy
From dictation software to full-blown natural language processing assistants, AI-based documentation tools promise to free clinicians from the tedium of charting. Physician burnout is on the rise—can AI-driven documentation help turn the tide? Strategies for successful change management, physician buy-in, and ongoing system optimization will be highlighted. How do we ensure data accuracy, privacy, and seamless integration into diverse electronic health records? Panelists will discuss the practical implementation of AI-assisted documentation and patient communication, while maintaining patient-centered care.
03:45 PM (EDT)
- 04:30 PM (EDT)
Novel Molecular and Genetic Therapies for Inherited Arrhythmia Syndrome and Arrhythmogenic Cardiomyopathies
Novel Molecular and Genetic Therapies for Inherited Arrhythmia Syndrome and Arrhythmogenic Cardiomyopathies
Dominic Abrams | Vassilios Bezzerides | Gabriel Brooks | Cain McClary
Inherited arrhythmia syndromes and cardiomyopathies pose a significant clinic challenge, with suboptimal treatment and a large unmet need. Over the last decade several new therapies have been developed which target the underlying genetic and molecular causes of these conditions, and many are progressing from pre-clinical research to clinical trials. These discoveries offer a potential paradigm shift in treatment strategies and quality of life for patients. This panel focused on novel genetic and molecular therapies for inherited arrhythmia syndromes and arrhythmogenic cardiomyopathies will bring together experts with a broad range of experience including venture capital, clinicians, translational scientists, and biotech. The session will address a wide range of topics from lab discovery to commercialization.
02:45 PM (EDT)
- 03:30 PM (EDT)
Pediatric EP and Cardiac Tech: Lifesaver or Just the Start?
Pediatric EP and Cardiac Tech: Lifesaver or Just the Start?
Brynn Dechert-Crooks | Benjamin Hale | Jamie Harris | Lisa Roelle | Nicholas Von Bergen
From life-changing interventions to emotional uncertainties, how does cardiac technology shape the journey of children and young adults with arrhythmias? This session explores the evolving role of electrophysiology (EP) in pediatrics, the impact of cutting-edge devices, and the patient experience—balancing fear, hope, and the promise of innovation. Are we maximizing technology’s potential, or is is there more to uncover in improving outcomes and quality of life for young patients?